semaj83/ctmatch_classification huggingface dataset:
Patient description: The patient is a 37-year-old woman who came to the clinic for a routine Pap smear. The test revealed stage 1B of cervical cancer. The patient tested positive for HPV 16. She has three sexual partners and four children. She underwent tubal ligation. She smokes 30 packs/year and drinks alcohol frequently. She is otherwise healthy. She was offered a radical hysterectomy.

Clinical trial eligibility criteria: eligible ages (years): 25.0-49.0,  Mass Screening Early Detection of Cancer Uterine Cervical Neoplasm Text Message Reminder Systems Women aged between 25 and 49 years Medical registration at any of the primary health care units selected for this study Eligible for cervical cancer screening* *Defined as all women aged between 25 and 60 years old who do not verify any of the following hysterectomized, active cervical cancer disease, currently undergoing cervical cancer treatment or did not start sexual activity  Unavailability of mobile phone number
Patient description: The patient is a 37-year-old woman who came to the clinic for a routine Pap smear. The test revealed stage 1B of cervical cancer. The patient tested positive for HPV 16. She has three sexual partners and four children. She underwent tubal ligation. She smokes 30 packs/year and drinks alcohol frequently. She is otherwise healthy. She was offered a radical hysterectomy.

Clinical trial eligibility criteria: eligible ages (years): 30.0-65.0,  Human Papilloma Virus 65 years old Female Live in southwest VA Not pregnant-self reported  History of Papanicolaou test in the last 3 years History of hysterectomy or pelvic radiation Co-testing (pap test and HPV test at the same time) in the last 5 years English speaking
Patient description: The patient is a 37-year-old woman who came to the clinic for a routine Pap smear. The test revealed stage 1B of cervical cancer. The patient tested positive for HPV 16. She has three sexual partners and four children. She underwent tubal ligation. She smokes 30 packs/year and drinks alcohol frequently. She is otherwise healthy. She was offered a radical hysterectomy.

Clinical trial eligibility criteria: eligible ages (years): 20.0-70.0,  Cervical Cancer Postoperative Pelvic Floor Dysfunction Criteria： ①Patients diagnosed as FIGO stage IA2、IB1、IIA1 cervical cancer ; ②Patients diagnosed as FIGO stage IB2、IIA2 cervical cancer, eligible for RH after neoadjuvant chemotherapy; ③Patients diagnosed as FIGO stage IIA endometrial carcinoma; ④Patients didn't have pelvic organ prolapse and urinary incontinence; ⑤Ability to hold Valsalva for dynamic MRI; ⑥Patients aged 20-70 years; ⑦Patients undergone RH surgery; ⑧Informed consent was signed  ： ①With MRI or urodynamic examination contraindication; ②Previously undergone POP or SUI surgery; ③BMI>30 With serious postoperative complications
Patient description: The patient is a 37-year-old woman who came to the clinic for a routine Pap smear. The test revealed stage 1B of cervical cancer. The patient tested positive for HPV 16. She has three sexual partners and four children. She underwent tubal ligation. She smokes 30 packs/year and drinks alcohol frequently. She is otherwise healthy. She was offered a radical hysterectomy.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Cancer Patients are those with a confirmed medical diagnosis of breast or thoracic cancer regardless of stage and followed at DCC for management The cancer diagnosis should have been made less than a year from the next scheduled appointment to the DCC The caregiver is defined as unpaid individuals involved in assisting the cancer patient with activities of daily living and/or medical tasks Patients and caregivers must be able to hear, read, and write in English; oriented to place, person, and time; and have an active telephone service, either cellular or landline  Excluding patients and caregivers who are less than 18 years of age
Patient description: The patient is a 37-year-old woman who came to the clinic for a routine Pap smear. The test revealed stage 1B of cervical cancer. The patient tested positive for HPV 16. She has three sexual partners and four children. She underwent tubal ligation. She smokes 30 packs/year and drinks alcohol frequently. She is otherwise healthy. She was offered a radical hysterectomy.

Clinical trial eligibility criteria: eligible ages (years): 25.0-65.0,  Cervical Cancer Screening Self-identify as transgender male or as transmasculine Assigned female sex at birth English speaking ages 25-65 years report not having had a pap smear in the last three years if age 30 and over, report not having a Pap smear/HPV co-test in the past 5 years  • Those who report having had a hysterectomy Those who report having history of cervical cancer Adults unable to consent Those who are pregnant Prisoners
Patient description: The patient is a 37-year-old woman who came to the clinic for a routine Pap smear. The test revealed stage 1B of cervical cancer. The patient tested positive for HPV 16. She has three sexual partners and four children. She underwent tubal ligation. She smokes 30 packs/year and drinks alcohol frequently. She is otherwise healthy. She was offered a radical hysterectomy.

Clinical trial eligibility criteria: eligible ages (years): 20.0-70.0,  Cervix Cancer Radiotherapy, Adjuvant Radiotherapy, Intensity-Modulated Hypofractionated Dose Chemotherapy, Concurrent histologically confirmed cervical cancer radical hysterectomy and pelvic lymph node dissection was done histologically indicated adjuvant chemoradiotherapy (more than one as below) positive pelvic lymph node metastasis positive parametrial invasion positive tumor involvement on surgical margin ECOG performance status 0 or 1 Bone marrow function: granulocyte ≥1.0 x 1000/µl, platelet ≥30 x 1000/µl, hemoglobin ≥10 g/dl Kidney function: Creatinine <2.0 mg/dL, Bilirubin 1.5 mg/dl  positive distant metastasis (including retroperitoneal lymph node metastasis) previous history of pelvic radiotherapy more than 3 months after radical surgery for cervical cancer neoadjuvant chemotherapy was done previous history of other carcinoma except for thyroid cancer, skin cancer, in situ carcinoma on cervix
Patient description: The patient is a 37-year-old woman who came to the clinic for a routine Pap smear. The test revealed stage 1B of cervical cancer. The patient tested positive for HPV 16. She has three sexual partners and four children. She underwent tubal ligation. She smokes 30 packs/year and drinks alcohol frequently. She is otherwise healthy. She was offered a radical hysterectomy.

Clinical trial eligibility criteria: eligible ages (years): 20.0-70.0,  Cervix Cancer Radiotherapy, Adjuvant Radiotherapy, Intensity-Modulated Hypofractionated Dose histologically confirmed cervical cancer radical hysterectomy and pelvic lymph node dissection was done histologically indicated adjuvant radiotherapy ( more than one as below) 1. tumor size ≥4 cm 2. positive lymphovascular invasion 3. more than half stromal invasion depth ECOG performance status 0 or 1 Bone marrow function: granulocyte ≥1.0 x 1000/µl, platelet ≥30 x 1000/µl, hemoglobin ≥10 g/dl  positive pelvic lymph node metastasis positive distant metastasis (including retroperitoneal lymph node metastasis) positive tumor involvement on resection margin positive parametrial invasion previous history of pelvic radiotherapy more than 3 months after radical surgery for cervical cancer neoadjuvant chemotherapy was done previous history of other carcinoma except for thyroid cancer, skin cancer, in situ carcinoma on cervix
Patient description: The patient is a 37-year-old woman who came to the clinic for a routine Pap smear. The test revealed stage 1B of cervical cancer. The patient tested positive for HPV 16. She has three sexual partners and four children. She underwent tubal ligation. She smokes 30 packs/year and drinks alcohol frequently. She is otherwise healthy. She was offered a radical hysterectomy.

Clinical trial eligibility criteria: eligible ages (years): 25.0-70.0,  Cervical Cancer Histology confirmed cervical cancer Clinical stage Ib2 or IIa2 (FIGO 2009)  Patients who not suitable for surgery Personal history of pelvic radiotherapy
Patient description: The patient is a 37-year-old woman who came to the clinic for a routine Pap smear. The test revealed stage 1B of cervical cancer. The patient tested positive for HPV 16. She has three sexual partners and four children. She underwent tubal ligation. She smokes 30 packs/year and drinks alcohol frequently. She is otherwise healthy. She was offered a radical hysterectomy.

Clinical trial eligibility criteria: eligible ages (years): 18.0-75.0,  Hereditary Breast and Ovarian Cancer Mutation Index case Any person with an indication for a BRCA1/BRCA2 gene analysis and who has been offered panel screening. Age ≥18 years. Family member Family members will be eligible if the mutation identified in the Index Case is considered deleterious. Any family member to the first and second decree or a cousin of the Index Case. Family members from both sides of the family will be invited to take part. Age ≥18 years  People deprived of their civil liberties or who are under judicial protection or guardianship. Patients unable to answer the questionnaire for social or psychological reasons. Children of the index cases, of any age
Patient description: The patient is a 37-year-old woman who came to the clinic for a routine Pap smear. The test revealed stage 1B of cervical cancer. The patient tested positive for HPV 16. She has three sexual partners and four children. She underwent tubal ligation. She smokes 30 packs/year and drinks alcohol frequently. She is otherwise healthy. She was offered a radical hysterectomy.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Csf Leakage male/female patient candidate for an endoscopic endonasal transphenoidal surgery, who need repair of the sellar floor as part of the surgical procedure  Diabetes, heart diseases, immunological diseases, infectious diseases, bone diseases
Patient description: The patient is a 37-year-old woman who came to the clinic for a routine Pap smear. The test revealed stage 1B of cervical cancer. The patient tested positive for HPV 16. She has three sexual partners and four children. She underwent tubal ligation. She smokes 30 packs/year and drinks alcohol frequently. She is otherwise healthy. She was offered a radical hysterectomy.

Clinical trial eligibility criteria: eligible ages (years): 18.0-30.0,  Healthy Healthy males at 18 to 30 years old Free from antibiotics and probiotic products for at least 1 month Willing to participate in the study, consume the test product and perform all measurements  Sever physical diseases Intolerance to probiotics or eggs
Patient description: The patient is a 37-year-old woman who came to the clinic for a routine Pap smear. The test revealed stage 1B of cervical cancer. The patient tested positive for HPV 16. She has three sexual partners and four children. She underwent tubal ligation. She smokes 30 packs/year and drinks alcohol frequently. She is otherwise healthy. She was offered a radical hysterectomy.

Clinical trial eligibility criteria: eligible ages (years): 19.0-68.0,  Cervical Intraepithelial Neoplasia Cervix Neoplasm Indication of cervical conization  We excluded patients who were not treated by our department physicians or if the patient did not return for follow-up
Patient description: The patient is a 37-year-old woman who came to the clinic for a routine Pap smear. The test revealed stage 1B of cervical cancer. The patient tested positive for HPV 16. She has three sexual partners and four children. She underwent tubal ligation. She smokes 30 packs/year and drinks alcohol frequently. She is otherwise healthy. She was offered a radical hysterectomy.

Clinical trial eligibility criteria: eligible ages (years): 25.0-999.0,  Cervical Cancer HIV/AIDS ≥25 years of age HIV-positive Competent to understand study procedures and give informed consent  Currently pregnant Currently menstruating or having persistent vaginal discharge Previous hysterectomy Previous diagnosis of cervical cancer
Patient description: The patient is a 37-year-old woman who came to the clinic for a routine Pap smear. The test revealed stage 1B of cervical cancer. The patient tested positive for HPV 16. She has three sexual partners and four children. She underwent tubal ligation. She smokes 30 packs/year and drinks alcohol frequently. She is otherwise healthy. She was offered a radical hysterectomy.

Clinical trial eligibility criteria: eligible ages (years): 18.0-75.0,  Progression-Free-Survival Recurrence Overall Survival Participants' are as follows: 1. The primary breast cancer after surgical treatment, the pathological diagnosis of breast epithelial tumors (breast cancer), ER, PR and Her-2 immunohistochemical results were negative; 2. no recurrence of metastasis; 3. card score ≥ 60 points; 4. Female patients aged 18-75 years (including 18,75 years); 5. there is no serious organic or functional disorders, no drugs and food allergy; 6. willing to receive treatment, observation and inspection. Participants'  are as follow: 1. does not meet the criteria; 2. patients expected to survive <6 months; 3. combined with cardiovascular and cerebrovascular, liver, kidney, hematopoietic system of serious primary disease and mental illness; 4. breastfeeding, pregnancy or women preparing for pregnancy; 5. allergies and allergies to a variety of drugs; 6. are participating in other drug subjects
Patient description: The patient is a 37-year-old woman who came to the clinic for a routine Pap smear. The test revealed stage 1B of cervical cancer. The patient tested positive for HPV 16. She has three sexual partners and four children. She underwent tubal ligation. She smokes 30 packs/year and drinks alcohol frequently. She is otherwise healthy. She was offered a radical hysterectomy.

Clinical trial eligibility criteria: eligible ages (years): 30.0-49.0,  Human Papillomavirus Infection Cervical Cancer The District Health Management Team (DHMT), estimates that in 2011 there were 31,574 women 30-49 years of age on the Kweneng East catchment area, serviced by Scottish Livingstone Hospital and the 4 selected Health Clinics. Women will be clients of the health facility at one of the clinics (described below under recruitment), may come to the facility for cervical cancer screening after having been contacted by a community mobilizer, or women attending a community health campaign event (in the community). Participants under Research Question 1: 1022 women Participants under Research Question 2a: 24 providers and other stakeholders Participants under Research Question 2b: 27 women for in-depth interviews; 250 women for structured surveys. Service Delivery Model Age 30 to 49 years Not screened recently/never screened before, defined as No prior history of cervical cancer screening: Pap smear, VIA or HPV testing), or Prior screening, but result unknown and no treatment Prior screening occurred more than 5 years ago for HIV negative women or 3 years ago for HIV positive women HIV status is known (HIV positive result, or documented HIV negative result is less than 12 months ago) No history of prior abnormal screening or treatment/procedure on her cervix due to abnormal screening No history of cervical cancer Not currently pregnant; not less than 6 weeks postpartum  Woman does not meet the for age 29 years or younger and age 50 years or older Screened for cervical cancer in last 3 years if HIV positive, or in the last 5 years if HIV negative Had an abnormal cervical cancer screening and/ or treatment of cervix  History of cervical cancer HIV status unknown Pregnant (self-report or by pregnancy test confirmation Less than 6 weeks postpartum, prior hysterectomy Unable to participate and give informed consent Not interested in HPV self-collection Unwilling to give informed consent
Patient description: The patient is a 37-year-old woman who came to the clinic for a routine Pap smear. The test revealed stage 1B of cervical cancer. The patient tested positive for HPV 16. She has three sexual partners and four children. She underwent tubal ligation. She smokes 30 packs/year and drinks alcohol frequently. She is otherwise healthy. She was offered a radical hysterectomy.

Clinical trial eligibility criteria: eligible ages (years): 0.5-75.0,  Human Papilloma Virus Written, informed consent obtained prior to any study-specific procedures. 2. Evidence of HPV virus activation (viral DNA) or high risk of HPV infection. 3. Not suitable for routine treatment or invalid to antiviral drugs. 4. Patients with viral disease symptoms and confirmed by biopsy, regardless of the level of virus DNA. 5. Age less than 75 years. 6. Did not use Penicillin or β-lactam antibiotics, or the lowest dose of other antibiotics. 7. Initial hematopoietic reconstitution: neutrophils (ANC) ≥ 1,000/mm^3, platelet (PLT) ≥ 1,000/mm^3. 8. Proper renal and hepatic functions (ULN denotes "upper limit of normal range"): Creatinine ≤ 2*ULN, Bilirubin ≤ 2*ULN, SGOT/ SGPT ≤ 3*ULN. 9. If HPV-CTL is not from the patient's own, then the provider of HPV-CTL needs to meet the following did not receive chemotherapy or radiotherapy within 4 weeks prior to blood collection, and did not take any steroids for the previous week, did not use Penicillin or β-lactam antibiotics, or the lowest dose of other antibiotics white blood cells ≥ 3,500 / μl, lymphocytes ≥ 750 / μl. 10. Human immunodeficiency virus (HIV) test was negative  Subject or the donor of BMT recipient infected with HCV (HCV antibody positive), HBV (HBsAg positive), HIV (HIV antibody positive), HTLV (HTLV antibody positive), Treponema pallidum antibody positive or TB culture positive. 2. Subject is albumin-intolerant. 3. Subject with life expectancy less than 8 weeks. 4. Subject participated in other investigational somatic cell therapies within past 30 days. 5. Subject with positive pregnancy test result
Patient description: The patient is a 37-year-old woman who came to the clinic for a routine Pap smear. The test revealed stage 1B of cervical cancer. The patient tested positive for HPV 16. She has three sexual partners and four children. She underwent tubal ligation. She smokes 30 packs/year and drinks alcohol frequently. She is otherwise healthy. She was offered a radical hysterectomy.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Breast Cancer Diagnosed with non-invasive (stage 0) or invasive (stage 1, 2 and 3A) breast adenocarcinoma Age 18 years or above Are planned to undergo at least 3 cycles of taxane treatment (i.e. paclitaxel or docetaxel) Have no documented or observable psychiatric or neurological disorders that might interfere with study participation (e.g., dementia or psychosis) Signed informed consent  Have a history of neuropathy before taxane treatment due to other medical conditions: diabetes, peripheral vascular disease, HIV infection, significant degenerative or familial neurologic disorder, nerve compression injuries (i.e., carpal tunnel syndrome, brachial plexopathy, spinal stenosis, or spinal nerve root compression) Taking stable doses of medication on prescription or dietary supplements for peripheral neuropathy. Related medications are: gabapentin, pregabalin, nortriptyline, amitriptyline, duloxetine, venlafaxine; lidocaine, opioid tramadol and other narcotics; NSAIDs; glutamine, glutathione, vitamin E and vitamin B12; Patients need to agree not to initiate a new therapy two weeks before and during the study period Metastatic disease Have a diagnosis of ethanol addiction or dependence within the past 10 years Concurrent chemotherapy with neurotoxic chemotherapeutic agents (i.e. platinum compounds or vinca alcaloids) Severe or unstable cardio respiratory or musculoskeletal disease
Patient description: The patient is a 37-year-old woman who came to the clinic for a routine Pap smear. The test revealed stage 1B of cervical cancer. The patient tested positive for HPV 16. She has three sexual partners and four children. She underwent tubal ligation. She smokes 30 packs/year and drinks alcohol frequently. She is otherwise healthy. She was offered a radical hysterectomy.

Clinical trial eligibility criteria: eligible ages (years): 21.0-65.0,  Human Papilloma Virus Abnormal cytology of atypical squamous cells of undetermined significance (ASCUS) on Pap smear OR Low-grade squamous intra epithelial lesions (LSIL) on Pap smear OR Positive hrHPV on routine screening (positive HPV will be assumed to be high grade)  Patients who proceed to excisional procedures (loop electrosurgical excision procedure or cold knife conization) Pregnant patients Breastfeeding patients Immunocompromised patients
Patient description: The patient is a 37-year-old woman who came to the clinic for a routine Pap smear. The test revealed stage 1B of cervical cancer. The patient tested positive for HPV 16. She has three sexual partners and four children. She underwent tubal ligation. She smokes 30 packs/year and drinks alcohol frequently. She is otherwise healthy. She was offered a radical hysterectomy.

Clinical trial eligibility criteria: eligible ages (years): 21.0-40.0,  Healthy student in Parker University's Doctor of Chiropractic program and patient at the Parker University Wellness Clinic available to take part in the study for all 3 test days willing to forgo all non-normal daily activities and chiropractic treatments during the test days  pregnant previous major injury involving the extremities previous surgeries to an extremity joint; and known neurological or systemic diseases
Patient description: The patient is a 37-year-old woman who came to the clinic for a routine Pap smear. The test revealed stage 1B of cervical cancer. The patient tested positive for HPV 16. She has three sexual partners and four children. She underwent tubal ligation. She smokes 30 packs/year and drinks alcohol frequently. She is otherwise healthy. She was offered a radical hysterectomy.

Clinical trial eligibility criteria: eligible ages (years): 30.0-65.0,  Cancer Cervix women from 30 to 65 years old women living in french territorial division 37 ("Indre-et-Loire") no pap smear made in the three last years (ideally)  Follow-up in progress for positive screening
Patient description: The patient is a 37-year-old woman who came to the clinic for a routine Pap smear. The test revealed stage 1B of cervical cancer. The patient tested positive for HPV 16. She has three sexual partners and four children. She underwent tubal ligation. She smokes 30 packs/year and drinks alcohol frequently. She is otherwise healthy. She was offered a radical hysterectomy.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Cervical Cancer Uterine Cancer Female years and older Biopsy-proved cervical cancer or endometrial cancer within three months of study enrollment Standard-of-care (SOC) FDG PET/CT exam performed within 30 days of study enrollment  Female < 18 years old No history of cervical cancer or endometrial cancer Primary biopsy > 3 months of study enrollment Systemic therapy or radiation therapy initiated SOC FDG PET/CT exam performed > 30 days of study enrollment Therapeutic procedures (chemotherapy, radiation therapy) have been initiated Pregnancy or lactation Claustrophobia or inability to tolerate the imaging procedure on the PET/MR scanner Individual is not willing to give informed consent